Entering text into the input field will update the search result below

TG Therapeutics, Inc. (TGTX) CEO Michael Weiss on Q4 2019 Results - Earnings Call Transcript

Mar. 03, 2020 12:59 PM ETTG Therapeutics, Inc. (TGTX)5 Comments
SA Transcripts profile picture
SA Transcripts

TG Therapeutics, Inc. (NASDAQ:TGTX) Q4 2019 Results Earnings Conference Call March 3, 2020 8:00 AM ET

Company Participants

Jenna Bosco - VP, IR & Senior VP of Corporate Communications

Sean Power - CFO, Corporate Secretary & Treasurer

Michael Weiss - Executive Chairman, CEO & President

Conference Call Participants

Alethia Young - Cantor Fitzgerald

Matt Kaplan - Ladenburg Thalmann

Ed White - H.C. Wainwright & Company

Chris Howerton - Jefferies

Mayank Mamtani - B. Riley FBR


Greetings, and welcome to the TG Therapeutics Fourth Quarter Earnings Call. At this time all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. [Operator Instructions] As a reminder, this conference is being recorded.

I would now like to turn the conference over to your host, Jenna Bosco, Senior Vice President of Corporate Communications. Please go ahead.

Jenna Bosco

Thank you. Good morning, and welcome to our conference call regarding TG Therapeutics' fourth quarter and year end 2019 financial results and business update. I'm Jenna Bosco, TG's Senior Vice President of Corporate Communications, and I welcome you to our conference call today.

Following our Safe Harbor statement, Sean Power, our Chief Financial Officer, will provide a brief overview of our financial results and then turn the call over to Michael Weiss, the company's Executive Chairman and Chief Executive Officer, who will provide an update on the ongoing development of our lead compounds, ublituximab and umbralisib, as well as an overview of our overall company standing.

Before we begin, I would like to remind everyone that various remarks we make about our future expectations, plans and prospects constitute forward-looking statements for purposes of the Safe Harbor provisions under the Private Securities Litigation Reform Act of 1995. TG cautions that these forward-looking statements are subject to risks and uncertainties that may cause our actual

Recommended For You

Comments (5)

I don't know if the readout is going to be great or not. I do know that this delay in data could not have happened at a worse time.
jhod58 profile picture
or maybe it's a great time. the current environment could have blunted any pop due to results.
AMP Biotech Research profile picture
If you have some thoughts about chance of success for UNITY CLL PFS readout, please check out our post on ampbioresearch.com: www.ampbioresearch.com/...
Hurry up and wait some more.
”we are well beyond- even in the most rosy scenario, we are well beyond the GC median”
To report an error in this transcript, .Contact us to add your company to our coverage or use transcripts in your business. Learn more about Seeking Alpha transcripts here. Your feedback matters to us!

About TGTX

SymbolLast Price% Chg
Market Cap
Yield (TTM)
Rev Growth (YoY)
Short Interest
Prev. Close
Compare to Peers

More on TGTX

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.